Supporting Research

AABB is committed to protecting, supporting, and advancing research that drives innovation and progress in transfusion medicine and biotherapies. The Association champions robust, sustained federal funding for research, which is critical to shaping evidence-based policies, enhancing blood donor safety, and improving patient outcomes. AABB fosters collaboration among public and private stakeholders to address current and emerging challenges in the field.

Policy Priorities

1. Support funding for the National Institutes of Health (NIH) and other federal agencies that provide critical resources needed to advance research related to blood, transfusion medicine and biotherapies.
2. Support biovigilance as well as research related to patient and donor care and safety.
3. Encourage research related to blood availability and the collection, analysis and public reporting of data related to the blood system.

Activities

2025

2021

2020

2019